+ Filter



EBV Determinant Variant
Anti-EBV Determinant Variant Recombinant Antibody Products
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (CF34)-2) (scTCR-0335YC-S(P))
-
- Species Reactivity: EBV
- Epitope: TLRGRAYGL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (CF34)-3) (scTCR-0336YC-S(P))
-
- Species Reactivity: EBV
- Epitope: YLRGRAYGL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (LC13)-1) (scTCR-0337YC-S(P))
-
- Species Reactivity: EBV
- Epitope: FLRGRAFGL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (LC13)-2) (scTCR-0338YC-S(P))
-
- Species Reactivity: EBV
- Epitope: FLRGRAYVL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (LC13)-3) (scTCR-0339YC-S(P))
-
- Species Reactivity: EBV
- Epitope: FLRGRFYGL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (LC13)-4) (scTCR-0340YC-S(P))
-
- Species Reactivity: EBV
- Epitope: TLRGRAYGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: FLRGRAFGL
- MHC: HLA-B*08:01
- Human Anti-EBV Determinant Variant Recombinant Soluble TCR (clone (LC13)-5) (scTCR-0341YC-S(P))
-
- Species Reactivity: EBV
- Epitope: YLRGRAYGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: TLRGRAYGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: FLRGRAFGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: TLRGRAYGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: FLRGRAFGL
- MHC: HLA-B*08:01
-
- Species Reactivity: EBV
- Epitope: TLRGRAYGL
- MHC: HLA-B*08:01
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
It has been explored the in vivo memory cytotoxic T lymphocyte (CTL) response to an immunodominant HLA-B8-restricted epitope, FLRGRAYGL, from the latent EBV antigen, EBNA 3A. Remarkably, the immune response to HLA-B8-FLRGRAYGL is characterized by type III-biased TCR usage (the reproducible selection of clonal TCR sequences) identifiable in unrelated HLA-B8+ individuals.